Home › Meningioma › Connecticut › New Haven
Meningioma clinical trials in New Haven, CT
3 studies for Meningioma are looking for participants at sites in and around New Haven (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Comparing the Radiopharmaceutical Drug, [177Lu]Lu-DOTATATE, to Standard of Care Treatment for Patients With Meningioma That Has Come Back After Prior Treatment
RecruitingPhase 2
- Yale University, New Haven
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas
RecruitingPhase 2
- Yale University, New Haven
A Study of JZP3507 (ONC206) in Recurrent Grade 2 or 3 Meningioma
RecruitingPhase 2
- Yale-New Haven Hospital - Yale Cancer Center, New Haven
Meningioma trials in other cities
- New York City, NY8 studies
- San Francisco, CA7 studies
- Miami, FL7 studies
- Columbus, OH6 studies
- Boston, MA6 studies
- Atlanta, GA5 studies
- San Diego, CA5 studies
- Jacksonville, FL5 studies
- Houston, TX4 studies
- Detroit, MI4 studies
- Durham, NC4 studies
- Arlington, VA4 studies
Other studies in New Haven
- Non-Small Cell Lung Cancer40 studies
- Breast Cancer38 studies
- Cancer (all types)35 studies
- Lung Cancer24 studies
- Colorectal Cancer23 studies
- Head and Neck Squamous Cell Carcinoma22 studies
- Metastatic Cancer22 studies
- Prostate Cancer22 studies
- Ovarian Cancer20 studies
- Opioid Overdose19 studies
- Acute Myeloid Leukemia18 studies
- Alcohol Use Disorder (AUD)18 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.